AG00HXCN

145040-37-5 | Candesartancilexetil

Chemical structure of Candesartancilexetil, CAS 145040-37-5
AG00HXCN
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 145040-37-5
Catalog Number AG00HXCN(AGN-PC-0WACQD)
Chemical Name Candesartancilexetil
IUPAC Name 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
InChI InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
InChI Key GHOSNRCGJFBJIB-UHFFFAOYSA-N
MDL Number MFCD00871371
Molecular Formula C33H34N6O6
Molecular Weight 610.6597
NSC Number 758697
SMILES O=C(C1=C2N(CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)C(OCC)=NC2=CC=C1)OC(OC(OC6CCCCC6)=O)C
Synonyms
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate, Amias, Atacand, Blopress, candesartan cilexetil, Kenzen, Parapres, TCV 116, TCV-116, Candesartan cilexetil, 145040-37-5, Atacand, TCV-116, Amias, Parapres, Kenzen, TCV 116, Candesartan (Cilexetil), CANDESARTAN CILEXTIL, candesartancilexetil, Candesartan cilexetil [USAN], CHEMBL1014, CHEBI:3348, TCY 116, C33H34N6O6, MFCD00871371, AK-75900, 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-, 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester, (+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester), 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate, 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate, 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate, 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate, 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate, 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-, 2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER, Racanda, Candesartan hexetil, 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate, candesartan cilexitil, Spectrum_001707, AC1L1DWQ, DSSTox_CID_239, Spectrum2_000485, Spectrum3_000996, Spectrum4_001124, Spectrum5_001462, DSSTox_RID_85567, Candesartan-cilexetil-Atacand, DSSTox_GSID_20239, SCHEMBL40831, BSPBio_002691, KBioGR_001607, KBioSS_002187, MLS004774127, Candesartan cilexetil , 97%, SPECTRUM1504261, SPBio_000349, GTPL8352, Candesartan cilexetil (Atacand), DTXSID5020239, KBio2_002187, KBio2_004755, KBio2_007323, KBio3_001911, KS-00000IVU, EBD4212, GHOSNRCGJFBJIB-UHFFFAOYSA-N, HMS1922J09, HMS2093E20, HMS3651I08, Pharmakon1600-01504261, BCP22050, Candesartan cilexetil (JP17/USAN), Tox21_302202, AC-204, BDBM50318907, BG0573, CCG-39530, NSC758697, s2037, STL451065, AKOS015894954, AKOS015920180, AB07617, AM90293, AN-7256, BCP9000480, CCG-222334, CS-2893, DB00796, DS-1302, KS-1147, NSC-758697, VA10473, Candesartan cilexetil, >=98% (HPLC), NCGC00095123-01, NCGC00095123-02, NCGC00095123-03, NCGC00255218-01, 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate, BC209195, BR-75900, HY-17505, LS-32741, SC-12740, SMR003500784, SBI-0206767.P001, AB0012012, AB2000442, TL8000995, 4CH-009595, C-265, CAS-145040-37-5, FT-0082579, FT-0602914, ST24030238, SW220041-1, A-2005, C07709, D00626, J10436, AB01274805-01, AB01274805_02, AB01274805_03, 040C375, H212/91, L006257, SR-05000001976, Atacand;Amias;Blopress;Ratacand;TCV 116;TCY 116, Camptothecine, Antibiotic for Culture Media Use Only, I06-0090, Q-200786, SR-05000001976-1, BRD-A65671304-001-02-6, BRD-A65671304-001-03-4, Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard, Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard, Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard, Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard, Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material, (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate, (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate, 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethox, 1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate, 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate, 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate, 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate, 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate, 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate., 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, ( -)-, 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, 2-Ethoxy-1-[2'-(1H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-benzimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester, 2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester, 2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester, 2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe, Blopress, candesartan, Ratacand, Atacand (TN), ATACAND HCT, UNII-R85M2X0D68, PBCMNDESARTAN CILEXETIL, CID2540, R85M2X0D68, C33-H34-N6-O6, ACN-037206, CS-O-00538, C2635, C077793, Candesartan cilexetil, 98%, an ATR antagonist - 1G 1g,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited